Biomarkers and Eosinophil Levels in Severe or Uncontrolled Asthma
The key opinion leaders explore the utilization of biomarkers in guiding the treatment of severe or uncontrolled asthma, discussing the specific role of eosinophils in informing therapeutic decision-making for patients with challenging asthma cases.
EP: 1.External Factors and Seasonality of Asthma
EP: 2.Endotypes and Phenotypes in Asthma
EP: 3.Type 2 Inflammation and Biomarkers in Asthma
EP: 4.Moderate/Severe/Uncontrolled Asthma Classification
EP: 5.Thinking About Endotypes when Managing Asthma
EP: 6.Use of Oral Corticosteroids in Asthma
EP: 7.High Oral Corticosteroid Dose and Exposure in Asthma
EP: 8.Oral Corticosteroid Overuse and Uncontrolled Asthma
Now Viewing
EP: 9.Biomarkers and Eosinophil Levels in Severe or Uncontrolled Asthma
EP: 10.Biologics in Asthma
EP: 11.GINA Guidelines and Biologics for Treatment of Asthma
EP: 12.Use of Biologics for Asthma in Patients with Allergies
EP: 13.Treatment of Asthma in Pediatric Patients
EP: 14.Atopic March in Pediatric Patients
EP: 15.Use of Biologics in Pediatric Patients and Conversations with Parents
EP: 16.Biologic Options in Pediatric Asthma
EP: 17.Advice for Clinicians Managing Asthma
Video content above is prompted by the following question(s):
- Which biomarkers do you use to guide treatment of severe or uncontrolled asthma?
- What factors can change eosinophil levels?
- How often are these factors considered when treating asthma?
Recent Videos
Related Content
